Yoshio Shirai
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 24
- Colorectal Cancer Treatments and Studies 9
- Cancer Diagnosis and Treatment 9
-
- Gallbladder and Bile Duct Disorders 24
- Gastric Cancer Management and Outcomes 13
- Surgery top 1%
- Cholangiocarcinoma and Gallbladder Cancer Studies 52
- Cancer Research top 10%
-
- Plant Disease Resistance and Genetics 11
- Co-authors
- Katsuyoshi HatakeyamaToshifumi WakaiKazuhiro TsukadaNaoyuki YokoyamaYoichi AjiokaTerukazu MutoShigenori NagakuraJun Sakata
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Yoshio Shirai
120 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 111
- Hepatology 671
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 1.8k
- Surgery 2.4k
- Cancer Research 217
Countries citing papers authored by Yoshio Shirai
This map shows the geographic impact of Yoshio Shirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Shirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Shirai more than expected).
Fields of papers citing papers by Yoshio Shirai
This network shows the impact of papers produced by Yoshio Shirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Shirai. The network helps show where Yoshio Shirai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshio Shirai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 5 | |
| 2 | 2012 | 88 | |
| 3 | 2011 | 10 | |
| 4 | 2009 | 3 | |
| 5 | 2008 | 49 | |
| 6 | 膵Solid-pseudopapillary Tumorの1成人男性例 | 2008 | 0 |
| 7 | 2008 | 3 | |
| 8 | 2008 | 0 | |
| 9 | 2008 | 73 | |
| 10 | 2007 | 3 | |
| 11 | 2007 | 54 | |
| 12 | 2006 | 16 | |
| 13 | 2004 | 37 | |
| 14 | 2003 | 61 | |
| 15 | 2001 | 5 | |
| 16 | 1996 | 12 | |
| 17 | 1995 | 10 | |
| 18 | 1993 | 18 | |
| 19 | 1992 | 1 | |
| 20 | 1992 | 0 |
About Yoshio Shirai
Yoshio Shirai is a scholar working on Hepatology, Oncology and Surgery, having authored 128 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (52 papers), Pancreatic and Hepatic Oncology Research (24 papers), Gallbladder and Bile Duct Disorders (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Gastric Cancer Management and Outcomes (13 papers), Plant Disease Resistance and Genetics (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Hepatology (671 citations), Oncology (1.7k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Yoshio Shirai has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Katsuyoshi Hatakeyama, Toshifumi Wakai, Kazuhiro Tsukada, Naoyuki Yokoyama, Yoichi Ajioka, Terukazu Muto, Shigenori Nagakura, Jun Sakata, Jun Sakata and Keisuke Yoshida. Their work appears in journals such as Cancer, Annals of Surgery and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.